Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
04.03.Publicis Health UK promotes Katie McMorran and Clare Middleton as Langland group managing directors
04.03.Women in pharma
01.03.UKRI appoints iiCON to deliver £1.5m initiative to tackle infection transmission
01.03.FDA awards Orphan Drug Designation to SynaptixBio for rare brain disease therapy
01.03.Sanofi presents positive results for rilzabrutinib in chronic spontaneous urticaria
01.03.Shaping up for launch in '24: three areas to explore for pharma
29.02.Radboud researchers use new method to improve diagnosis of rare diseases
29.02.OneChain-led consortium granted €1.9m to advance CAR-T therapy for rare leukaemia
29.02.Clinigen launches 'What is Possible?' campaign on Rare Disease Day to accelerate access to medicines
29.02.CHMP recommends Travere and CSL Vifor's Filspari to treat rare kidney disease IgAN
29.02.The pharma trailblazer's skill set: forged in rare diseases
29.02.Rare diseases - driving further improvements in patient access
29.02.Overcoming challenges in rare disease research with patients
28.02.BeiGene's tislelizumab receives CHMP recommendation for non-small cell lung cancer
28.02.ICR study reveals AstraZeneca's ceralasertib sensitises tumours to immunotherapy
28.02.VML Health announces trio of appointments to creative leadership team
28.02.Valuable research insights to steer pharma's HCP engagement impact
28.02.Committing to diversity: the key to pharmaceutical supply chain resilience
28.02.FDA approves Allecra's combination antibiotic Exblifep for complicated UTIs
27.02.Novo Nordisk and Neomorph enter molecular glue degrader partnership worth over $1.4bn
27.02.AstraZeneca's Voydeya receives CHMP recommendation for rare blood disease PNH
27.02.Novartis and Genentech's Xolair shown to significantly reduce allergic reactions to food
27.02.Janssen's Carvykti recommended by CHMP for earlier multiple myeloma treatment
27.02.Researchers develop screening tool to investigate mechanisms behind multiple diseases
27.02.Landmark project boosts sex and gender equity in UK medical research